Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Emmanuel Stip, MD, MSc, CSPQ
JCP
Letter to the Editor
Cost Reductions Associated With Long-Acting Injectable Antipsychotics According to Patient Age
October 25, 2017
Emmanuel Stip
JCP
Letter to the Editor
Physician Characteristics Associated With Prescription of Long-Acting Injectable Antipsychotics
October 25, 2017
Emmanuel Stip
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder
June 14, 2011
William G. Honer
,
G. William MacEwan
,
Alain Gendron
, et al
JCP
Original Research
Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia: A Meta-Analysis
April 16, 2007
Amir Ali Sepehry
,
Stéphane Potvin
,
Robert Élie
, et al
JCP
Original Research
Neural Correlates of the Affect Regulation Model in Schizophrenia Patients With Substance Use History: A Functional Magnetic Resonance Imaging Study
March 15, 2006
Adham Mancini-Marïe
,
Stéphane Potvin
,
Cherine Fahim
, et al
JCP
Letter to the Editor
Need for a New Framework to Understand the Mechanism of All Antipsychotics
October 31, 2000
Emmanuel Stip
,
Peter F. Liddle
,
Jean Paul Soucy
